1. |
Riikonen R. Epidemiological data of west syndrome in Finland. Brain Dev, 2001, 23(7): 539-541.
|
2. |
Shields WD. Infantile spasms: little seizures, BIG consequences. Epilepsy Curr, 2006, 6(3): 63-69.
|
3. |
Frost JD Jr, Hrachovy RA. Pathogenesis of infantile spasms: a model based on developmental desynchronization. J Clin Neurophysiol, 2005, 22(1): 25-36.
|
4. |
Hrachovy RA. West’s syndrome (infantile spasms). Clinical description and diagnosis. Adv Exp Med Biol, 2002, 497: 33-50.
|
5. |
Dulac O, Soufflet C, Chiron C, et al. What is West syndrome? Int Rev Neurobiol, 2002, 49: 1-22.
|
6. |
Kellaway P, Hrachovy RA, Frost JD Jr, et al. Precise characterization and quantification of infantile spasms. Ann Neurol, 1979, 6(3): 214-218.
|
7. |
Baram TZ. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurol, 1993, 33(3): 231-236.
|
8. |
Scheffer IE, French J, Hirsch E, et al. Classification of the epilepsies: New concepts for discussion and debate—Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology. Epilepsia Open, 2016, 1(1-2): 37-44.
|
9. |
Sorel L, Dusaucy-Bauloye A. Findings in 21 cases of Gibbs’ hypsarrhythmia; spectacular effectiveness of ACTH. Acta Neurol Psychiatr Belg, 1958, 58(2): 130-141.
|
10. |
Hrachovy RA, Frost JD Jr, Kellaway P, et al. Double-blind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr, 1983, 103(4): 641-645.
|
11. |
Hrachovy RA, Frost JD Jr, Glaze DG. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr, 1994, 124(5 Pt 1): 803-836.
|
12. |
Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics, 1996, 97(3): 375-379.
|
13. |
Lux AL, Edwards SW, Hancock E, et al. The united kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet, 2004, 364(9447): 1773-1778.
|
14. |
Chu-Shore CJ, Major P, Camposano S, et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia, 2010, 51(7): 1236-1241.
|
15. |
Zeng LH, Xu L, Gutmann DH, et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol, 2008, 63(4): 444-453.
|
16. |
Meikle L, Pollizzi K, Egnor A, et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci, 2008, 28(21): 5422-5432.
|
17. |
Stafstrom CE, Moshe SL, Swann JW, et al. Models of pediatric epilepsies: strategies and opportunities. Epilepsia, 2006, 47(8): 1407-1414.
|
18. |
Stafstrom CE. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr, 2009, 9(3): 75-81.
|
19. |
Marsh ED, Golden JA. Developing an animal model for infantile spasms: pathogenesis, problems and progress. Dis Model Mech, 2009, 2(7-8): 329-335.
|
20. |
Stafstrom CE, Holmes GL. Infantile spasms: criteria for an animal model. Int Rev Neurobiol, 2002, 49: 391-411.
|
21. |
Stromme P, Mangelsdorf ME, Scheffer IE, et al. Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX. Brain Dev, 2002, 24(5): 266-268.
|
22. |
Stromme P, Mangelsdorf ME, Shaw MA, et al. Mutations in the human ortholog of aristaless cause x-linked mental retardation and epilepsy. Nat Genet, 2002, 30(4): 441-445.
|
23. |
Olivetti PR, Maheshwari A, Noebels JL. Neonatal estradiol stimulation prevents epilepsy in arx model of x-linked infantile spasms syndrome. Sci Transl Med, 2014, 6(220): 220ra12.
|
24. |
Stafstrom CE. Epilepsy in Down Syndrome: Clinical Aspects and Possible Mechanisms. Am J Ment Retard, 1993, 98(suppl): 12.
|
25. |
Stafstrom CE, Konkol RJ. Infantile spasms in children with down syndrome. Dev Med Child Neurol, 1994, 36(7): 576-585.
|
26. |
Joshi K, Shen L, Michaeli A, et al. Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel. Ann Neurol, 2016, 80(4): 511-521.
|
27. |
Chachua T, Yum MS, Veliskova J, et al. Validation of the rat model of cryptogenic infantile spasms. Epilepsia, 2011, 52(9): 1666-1677.
|
28. |
Yum MS, Chachua T, Veliskova J, et al. Prenatal stress promotes development of spasms in infant rats. Epilepsia, 2012, 53(3): e46-49.
|
29. |
Tsuji M, Takahashi Y, Watabe AM, et al. Enhanced long-term potentiation in mature rats in a model of epileptic spasms with betamethasone-priming and postnatal N-methyl-D-aspartate administration. Epilepsia, 2016, 57(3): 495-505.
|
30. |
Price MG, Yoo JW, Burgess DL, et al. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci, 2009, 29(27): 8752-8763.
|
31. |
Chachua T, Di Grazia P, Chern CR, et al. Estradiol does not affect spasms in the beta methasone-NMDA rat model of infantile spasms. Epilepsia, 2016, 57(8): 1326-1336.
|
32. |
Shi XY, Yang XF, Tomonoh Y, et al. Development of a mouse model of infantile spasms induced by N-methyl-D-aspartate. Epilepsy Res, 2015, 118: 29-33.
|
33. |
Shi XY, Ju J, Zou LP, et al. Increased precipitation of spasms in an animal model of infantile spasms by prenatal stress exposure. Life Sci, 2016, 152: 171-177.
|
34. |
De Weerth C, Buitelaar JK. Physiological stress reactivity in human pregnancy--a review. Neurosci Biobehav Rev, 2005, 29(2): 295-312.
|
35. |
Murphy BE, Clark SJ, Donald IR, et al. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol, 1974, 118(4): 538-541.
|
36. |
Brunson KL, Avishai-Eliner S, Baram TZ. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol, 2002, 49: 185-197.
|
37. |
Scantlebury MH, Galanopoulou AS, Chudomelova L, et al. A model of symptomatic infantile spasms syndrome. Neurobiol Dis, 2010, 37(3): 604-612.
|
38. |
Galanopoulou AS, Mowrey WB, Liu W, et al. Preclinical Screening for treatments for infantile spasms in the multiple hit rat model of infantile spasms: An Update. Neurochem Res, 2017, 42(7): 1949-1961.
|
39. |
Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia, 2010, 51(10): 2175-2189.
|
40. |
Galvan CD, Hrachovy RA, Smith KL, et al. Blockade of neuronal activity during hippocampal development produces a chronic focal epilepsy in the rat. J Neurosci, 2000, 20(8): 2904-2916.
|
41. |
Lee CL, Frost JD Jr, Swann JW, et al. A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia, 2008, 49(2): 298-307.
|
42. |
Frost JD Jr, Le JT, Lee CL, et al. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms. Neurobiol Dis, 2015, 82: 1-11.
|